Journal of Cataract & Refractive Surgery
Volume 35, Issue 9 , Pages 1518-1522 , September 2009

Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration

Received 18 February 2009 ,Revised 4 April 2009 ,Accepted 8 April 2009.

References 

  1. Jonas JB, Kreissig I, Budde WM, Degenring RF. Cataract surgery combined with intravitreal injection of triamcinolone acetonide. Eur J Ophthalmol. 2005;15:329–335
  2. Estafanous MFG, Lowder CY, Meisler DM, Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol. 2001;131:620–625
  3. The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572
  4. Klein R, Klein BEK, Knudtson MD, Wong TY, Cotch MF, Liu K, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006;113:373–380
  5. Age-Related Eye Disease Study Research Group. Potential pubic health impact of age-related eye disease study results; AREDS report no. 11. Arch Ophthalmol. 2003;121:1621–1624
  6. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration; a case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report number 3. Ophthalmology. 2000;107:2224–2232
  7. West SK, Rosenthal FS, Bressler NM, Bressler SB, Munoz B, Fine SL, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989;107:875–879
  8. Sperduto RD, Hiller R, Seigel D. Lens opacities and senile maculopathy. Arch Ophthalmol. 1981;99:1004–1008
  9. Liu IY, White L, LaCroix AZ. The association of age- related macular degeneration and lens opacities in the aged. Am J Public Health. 1989;79:765–769Available at: http://www.ajph.org/cgi/reprint/79/6/765Accessed May 15, 2009
  10. Bockelblink A, Roll S, Ruether K, Rasch R, Greiner W, Willich SN. Cataract surgery and the development or progression of age-related macular degeneration: a systematic review. Surv Ophthalmol. 2008;53:359–367
  11. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration; twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;112:1035–1047
  12. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363–372
  13. Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol. 2006;142:1–9
  14. Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM. Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration. Retina. 2006;26:994–998
  15. Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, et al. Intravitreal bevacizumab for treatment of naïve subfoveal occultchoroidal neovascularization in age-related macular degeneration. Acta Ophthalmol (Oxford). 2009;87:404–407
  16. The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol. 2001;131:167–175
  17. Biro Z, Balla Z, Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye. 2008;22:8–12Available at: http://www.nature.com/eye/journal/v22/n1/pdf/6702460a.pdfAccessed May 15, 2009
  18. Grewing R, Besker H. Retinal thickness immediately after cataract surgery measured by optical coherence tomography. Ophthalmic Surg Laser. 2000;31:215–217
  19. Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol. 1959;47(5, part 2):155–170
  20. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration. Ophthalmic Surg Laser Imaging. 2005;36:331–335
  21. Pollack A, Buckelman A, Zalish M, Leiba H, Oliver H. The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Laser. 1998;29:286–294
  22. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology. 1996;103:1546–1554
  23. Chine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod M-A, Schutz D, et al. Case-control study of the risk factors for age related macular degeneration; for FRANCE-DMLA Study Group. Br J Ophthalmol. 1998;82:996–1002Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1722735&blobtype=pdfAccessed May 15, 2009
  24. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age related maculopathy in a 14-year follow-up study; the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2005;83:409–418Available at: http://www3.interscience.wiley.com/cgi-bin/fulltext/118668642/PDFSTARTAccessed May 15, 2009
  25. Cugati S, Mitchell P, Rochtchina E, Tan AG, Smith W, Wang JJ. Cataract surgery and the 10-year incidence of age-related maculopathy; the Blue Mountains Eye Study. Ophthalmology. 2006;113:2020–2025
  26. Pham TQ, Cugati S, Rochtchina E, Mitchell P, Maloof A, Wang JJ. Early age-related maculopathy in eyes after cataract surgery. Eye. 2007;21:512–517
  27. Wang JJ, Klein R, Smith W, Klein BEK, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy; pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology. 2003;110:1960–1967
  28. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration; an Australian case-control study. Ophthalmology. 1997;104:770–776
  29. Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol. 2000;84:1343–1348Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1723362&blobtype=pdfAccessed May 15, 2009
  30. Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: one year outcomes. J Cataract Refract Surg. 2003;29:686–693
  31. Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration. Ophthalmology. 2007;114:278–282
  32. Sutter FKP, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, et al. Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Invest Ophthalmol Vis Sci. 2007;48:1472–1475Available at: http://www.iovs.org/cgi/reprint/48/4/1472Accessed May 15, 2009
  33. Baatz H, Darawsha R, Ackermann H, Scharioth GB, de Ortueta D, Pavlidis M, et al. Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:1079–1083Available at: http://www.iovs.org/cgi/reprint/49/3/1079Accessed May 15, 2009
  34. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PTVM. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997;81:154–162Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1722110&blobtype=pdfAccessed May 15, 2009
  35. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676Available at: http://www.nature.com/nm/journal/v9/n6/pdf/nm0603-669.pdfAccessed May 15, 2009
  36. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 1990;50:1774–1778Available at: http://cancerres.aacrjournals.org/cgi/reprint/50/6/1774Accessed May 15, 2009
  37. Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47(suppl 1):S203–S218

 No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(09)00560-4

doi: 10.1016/j.jcrs.2009.04.032

Journal of Cataract & Refractive Surgery
Volume 35, Issue 9 , Pages 1518-1522 , September 2009

Article Tools

* Image Usage & Resolution